Your browser doesn't support javascript.
loading
Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population.
Schmidt, Marcus; Weyer-Elberich, Veronika; Hengstler, Jan G; Heimes, Anne-Sophie; Almstedt, Katrin; Gerhold-Ay, Aslihan; Lebrecht, Antje; Battista, Marco J; Hasenburg, Annette; Sahin, Ugur; Kalogeras, Konstantine T; Kellokumpu-Lehtinen, Pirkko-Liisa; Fountzilas, George; Wirtz, Ralph M; Joensuu, Heikki.
Afiliação
  • Schmidt M; Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany. marcus.schmidt@unimedizin-mainz.de.
  • Weyer-Elberich V; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany.
  • Hengstler JG; Leibniz Research Centre for Working Environment and Human Factors (IfADo) at Dortmund TU, Dortmund, Germany.
  • Heimes AS; Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
  • Almstedt K; Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
  • Gerhold-Ay A; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany.
  • Lebrecht A; Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
  • Battista MJ; Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
  • Hasenburg A; Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
  • Sahin U; TRON-Translational Oncology at the University Medical Center Mainz, Mainz, Germany.
  • Kalogeras KT; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Kellokumpu-Lehtinen PL; Translational Research Section, Hellenic Cooperative Oncology Group, Athens, Greece.
  • Fountzilas G; Department of Oncology, Tampere University Hospital and University of Tampere, Tampere, Finland.
  • Wirtz RM; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Joensuu H; Aristotle University of Thessaloniki, Thessaloniki, Greece.
Breast Cancer Res ; 20(1): 15, 2018 02 26.
Article em En | MEDLINE | ID: mdl-29482642

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos CD4 / Fatores de Transcrição Forkhead / Quimiocina CXCL13 / Neoplasias de Mama Triplo Negativas Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos CD4 / Fatores de Transcrição Forkhead / Quimiocina CXCL13 / Neoplasias de Mama Triplo Negativas Idioma: En Ano de publicação: 2018 Tipo de documento: Article